<bill session="118" type="h" number="5207" updated="2024-07-24T15:20:38Z">
  <state datetime="2023-08-15">REFERRED</state>
  <status>
    <introduced datetime="2023-08-15"/>
  </status>
  <introduced datetime="2023-08-15"/>
  <titles>
    <title type="display">To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.</title>
  </titles>
  <sponsor bioguide_id="B001260"/>
  <cosponsors>
    <cosponsor bioguide_id="F000466" joined="2023-08-15"/>
    <cosponsor bioguide_id="K000376" joined="2023-08-15"/>
  </cosponsors>
  <actions>
    <action datetime="2023-08-15">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-08-15" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary date="2023-09-18T17:29:13Z" status="Introduced in House">This bill expands the tax credit for increasing research activities to add a new credit amount equal to 14% of specified medical research expenditures. The bill defines specified medical research expenditures as amounts paid or incurred for research with respect to any qualified countermeasure (i.e., a drug, biological product, or device determined to be a priority in protecting against harm from a biological agent or adverse health condition).</summary>
</bill>
